BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12435085)

  • 1. A maximal effort trial in obese women carrying the beta2-adrenoceptor Gln27Glu polymorphism.
    Macho-Azcárate T; Calabuig J; Martí A; Martínez JA
    J Physiol Biochem; 2002 Jun; 58(2):103-8. PubMed ID: 12435085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain.
    González Sánchez JL; Proenza AM; Martínez Larrad MT; Ramis JM; Fernández Pérez C; Palou A; Serrano Ríos M
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):476-81. PubMed ID: 14510910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women.
    Macho-Azcarate T; Marti A; González A; Martinez JA; Ibañez J
    Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1434-41. PubMed ID: 12439644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal fat oxidation and after a peak oxygen consumption test in obese women with a beta2 adrenoceptor gene polymorphism.
    Macho-Azcarate T; Marti A; Calabuig J; Martinez JA
    J Nutr Biochem; 2003 May; 14(5):275-9. PubMed ID: 12832031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation.
    Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2006 Oct; 19(10):1084-91. PubMed ID: 17027833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between a human beta-2 adrenoceptor gene polymorphism (gln27glu) and morbid obesity.
    Kortner B; Wolf A; Wendt D; Beisiegel U; Evans D
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1099-100. PubMed ID: 10557032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females.
    Hellström L; Large V; Reynisdottir S; Wahrenberg H; Arner P
    J Intern Med; 1999 Mar; 245(3):253-9. PubMed ID: 10205587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism.
    Martínez JA; Corbalán MS; Sánchez-Villegas A; Forga L; Marti A; Martínez-González MA
    J Nutr; 2003 Aug; 133(8):2549-54. PubMed ID: 12888635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common variants in the beta2-(Gln27Glu) and beta3-(Trp64Arg)--adrenoceptor genes are associated with elevated serum NEFA concentrations and type II diabetes.
    Carlsson M; Orho-Melander M; Hedenbro J; Groop LC
    Diabetologia; 2001 May; 44(5):629-36. PubMed ID: 11380082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADRB2 haplotype is associated with glucose tolerance and insulin sensitivity in obese postmenopausal women.
    Prior SJ; Goldberg AP; Ryan AS
    Obesity (Silver Spring); 2011 Feb; 19(2):396-401. PubMed ID: 20829805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, Type II diabetes and the beta 2 adrenoceptor gene Gln27Glu polymorphism in the Tongan population.
    Duarte NL; Colagiuri S; Palu T; Wang XL; Wilcken DE
    Clin Sci (Lond); 2003 Mar; 104(3):211-5. PubMed ID: 12605574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men.
    Mori Y; Kim-Motoyama H; Ito Y; Katakura T; Yasuda K; Ishiyama-Shigemoto S; Yamada K; Akanuma Y; Ohashi Y; Kimura S; Yazaki Y; Kadowaki T
    Biochem Biophys Res Commun; 1999 Apr; 258(1):138-40. PubMed ID: 10222249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
    Isaza C; Henao J; Ramirez E; Cuesta F; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):237-44. PubMed ID: 16082424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gln27Glu polymorphism in β2-adrenergic receptor gene is linked to hypertriglyceridemia, hyperinsulinemia and hyperleptinemia in Saudis.
    Daghestani MH; Warsy A; Daghestani MH; Al-odaib AN; Eldali A; Al-Eisa NA; Al-zhrani S
    Lipids Health Dis; 2010 Aug; 9():90. PubMed ID: 20738880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the link between polymorphisms of the beta2 and beta3 adrenergic receptor gene and metabolic parameters among Polish Caucasians with familial obesity.
    Malczewska-Malec M; Wybrańska I; Leszczyńska-Gołabek I; Niedbał S; Kwaśniak M; Hartwich J; Kieć-Wilk B; Motyka M; Szopa M; Dembińska-Kieć A
    Med Sci Monit; 2003 Jun; 9(6):CR225-34. PubMed ID: 12824951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ADRB2 Gln27Glu and ADRB3 Trp64Arg polymorphisms on body weight and body composition changes after a controlled weight-loss intervention.
    Szendrei B; González-Lamuño D; Amigo T; Wang G; Pitsiladis Y; Benito PJ; Gomez-Candela C; Calderón FJ; Cupeiro R;
    Appl Physiol Nutr Metab; 2016 Mar; 41(3):307-14. PubMed ID: 26888112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
    Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of beta2-adrenoceptor Gln27Glu variant with body weight but not hypertension.
    Lin RCY ; Ericsson JO; Benjafield AV; Morris BJ
    Am J Hypertens; 2001 Dec; 14(12):1201-4. PubMed ID: 11775127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus.
    Ishiyama-Shigemoto S; Yamada K; Yuan X; Ichikawa F; Nonaka K
    Diabetologia; 1999 Jan; 42(1):98-101. PubMed ID: 10027586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the glutamine 27 glutamic acid polymorphism in the adrenoceptor β2 surface gene on obesity and metabolic phenotypes in Taiwan.
    Hsiao TJ; Lin E
    J Investig Med; 2014 Feb; 62(2):310-5. PubMed ID: 24322328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.